Visceral obesity is associated with high levels of serum squalene

Obesity

Volumn 14, Issue 7, 2006, Pages 1155-1163

  Peltola, Paula ^a   Pihlajamäki, Jussi ^a,d   Koutnikova, Hana ^b   Ruotsalainen, Eija ^a   Salmenniemi, Urpu ^a   Vauhkonen, Ilkka ^a   Kainulainen, Sakari ^a   Gylling, Helena ^a   Miettinen, Tatu A ^c   Auwerx, Johan ^b   Laakso, Markku ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^c UNIVERSITY OF HELSINKI   (Finland)

^d JOSLIN DIABETES CENTER   (United States)

Author keywords

Cholesterol synthesis; Insulin resistance; Intra abdominal obesity; Squalene synthase; Type 2 diabetes

Indexed keywords

BIOLOGICAL MARKER; CHOLESTEROL; INSULIN; SQUALENE; SQUALENE SYNTHASE;

ADULT; ARTICLE; BIOSYNTHESIS; BLOOD; BODY COMPOSITION; FEMALE; GENETICS; GLUCOSE CLAMP TECHNIQUE; HUMAN; INTESTINE ABSORPTION; INTRAABDOMINAL FAT; MALE; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHYSIOLOGY; SINGLE STRAND CONFORMATION POLYMORPHISM;

ADULT; BIOLOGICAL MARKERS; BODY COMPOSITION; CHOLESTEROL; DIABETES MELLITUS, TYPE 2; FARNESYL-DIPHOSPHATE FARNESYLTRANSFERASE; FEMALE; GLUCOSE CLAMP TECHNIQUE; HUMANS; INSULIN; INTESTINAL ABSORPTION; INTRA-ABDOMINAL FAT; MALE; OBESITY; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; SQUALENE;

EID: 33846884414     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2006.132     Document Type: Article

References (35)

1. DeFronzo RA. Pathogenesis of type 2 (non-insulin dependent) diabetes mellitus: a balanced overview. Diabetologia. 1992;35:389-97.
2. Mykkänen L, Kuusisto J, Pyörälä K, Laakso M. Cardiovascular disease risk factors as predictors of type 2 (non-insulin- dependent) diabetes mellitus in elderly subjects. Diabetologia. 1993;36:553-9.
3. Simonen PP, Gylling HK, Miettinen TA. Diabetes contributes to cholesterol metabolism regardless of obesity. Diabetes Care. 2002;25:1511-5.
4. Pihlajamäki J, Gylling H, Miettinen TA, Laakso M. Insulin resistance is associated with increased cholesterol synthesis and decreased cholesterol absorption in normoglycemic men. J Lipid Res. 2004;45:507-12.
5. Adeli K, Taghibiglou C, Van Iderstine SC, Lewis GF. Mechanisms of hepatic very low-density lipoprotein overproduction in insulin resistance. Trends Cardiovasc Med. 2001;11:170-6.
6. Tobin KA, Ulven SM, Schuster GU, et al. Liver x receptors as insulin-mediating factors in fatty acid and cholesterol biosynthesis. J Biol Chem. 2002;277:10691-7.
7. Tilvis R, Miettinen TA. Effects of weight reduction on squalene, methyl sterols and cholesterol and on their synthesis in human adipose tissue. Eur J Clin Invest. 1979;9:155-60.
8. Tilvis R, Kovanen PT, Miettinen TA. Metabolism of squalene in human fat cells: demonstration of a two-pool system. J Biol Chem. 1982;257:10300-5.
9. Miettinen TA, Tilvis RS, Kesäniemi YA. Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population. Am J Epidemiol. 1990;131:20-31.
10. Laakso M, Uusitupa M, Takala J, Majander H, Reijonen T, Penttilä I. Effects of hypocaloric diet and insulin therapy on metabolic control and mechanisms of hyperglycemia in obese non-insulin-dependent diabetic subjects. Metabolism. 1988;37:1092-100.
11. Salmenniemi U, Ruotsalainen E, Pihlajamäki J, Laakso M. Multiple abnormalities in glucose and energy metabolism in offspring of patients with type 2 diabetes. Circulation. 2004;110:3842-48.
12. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications: I. Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15:539-53.
13. Galvin P, Ward G, Walters J, et al. A simple method for quantitation of insulin sensitivity and insulin release from an intravenous glucose tolerance test. Diabet Med. 1992;9:921-8.
14. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237:E214-23.
15. Sjöström L, Kvist H, Cederblad A, Tylen U. Determination of total adipose tissue and body fat in women by computed tomography, 40k, and tritium. Am J Physiol. 1986;250:E736-45.
16. Laakso M, Sarlund H, Mykkänen L. Insulin resistance is associated with lipid and lipoprotein abnormalities in subjects with varying degrees of glucose tolerance. Arteriosclerosis. 1990;10:223-31.
17. Gylling H, Miettinen TA. Inheritance of cholesterol metabolism of probands with high or low cholesterol absorption. J Lipid Res. 2002;43:1472-6.
18. Miettinen TA, Koivisto P. Non-cholesterol sterols and bile acid production in hypercholesterolaemic patients with ileal bypass. Bile Acids Cholesterol Health Disease. 1983;183-87.
19. Tansey TR, Shechter I. Structure and regulation of mammalian squalene synthase. Biochim Biophys Acta. 2000;1529:49-62.
20. Guan G, Jiang G, Koch RL, Shechter I. Molecular cloning and functional analysis of the promoter of the human squalene synthase gene. J Biol Chem. 1995;270:21958-65.
21. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of Id and haplotype maps. Bioinformatics. 2005;21:263-5.
22. Miettinen TA. Cholesterol production in obesity. Circulation. 1971;44:842-50.
23. Nestel PJ, Schreibman PH, Ahrens EH Jr. Cholesterol metabolism in human obesity. J Clin Invest. 1973;52:2389-97.
24. Miettinen TA, Gylling H. Cholesterol absorption efficiency and sterol metabolism in obesity. Atherosclerosis. 2000;153:241-8.
25. Miettinen TA, Gylling H. Synthesis and absorption markers of cholesterol in serum and lipoproteins during a large dose of statin treatment. Eur J Clin Invest. 2003;33:976-82.
26. Saudek CD, Frier BM, Liu GC. Plasma squalene: lipoprotein distribution and kinetic analysis. J Lipid Res. 1978;19:827-35.
27. Ugawa T, Kakuta H, Moritani H, et al. Ym-53601, a novel squalene synthase inhibitor, reduces plasma cholesterol and triglyceride levels in several animal species. Br J Pharmacol. 2000;131:63-70.
28. Francis GA, Fayard E, Picard F, Auwerx J. Nuclear receptors and the control of metabolism. Annu Rev Physiol. 2003;65:261-311.
29. Seo JB, Moon HM, Kim WS, et al. Activated liver x receptors stimulate adipocyte differentiation through induction of peroxisome proliferator-activated receptor gamma expression. Mol Cell Biol. 2004;24:3430-44.
30. Forman BM, Ruan B, Chen J, Schroepfer GJ Jr., Evans RM. The orphan nuclear receptor LXRalpha is positively and negatively regulated by distinct products of mevalonate metabolism. Proc NatlAcad Sci USA. 1997;94:10588-93.
31. Horton JD, Goldstein JL, Brown MS. Srebps: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest. 2002;109:1125-31.
32. Fajas L, Schoonjans K, Gelman L, et al. Regulation of peroxisome proliferator-activated receptor gamma expression by adipocyte differentiation and determination factor 1/sterol regulatory element binding protein 1: implications for adipocyte differentiation and metabolism. Mol Cell Biol. 1999;19:5495-503.
33. Kim JB, Wright HM, Wright M, Spiegelman BM. Add1/srebpl activates PPARgamma through the production of endogenous ligand. Proc Natl Acad Sci USA. 1998;95:4333-7.
34. Hiyoshi H, Yanagimachi M, Ito M, et al. Squalene synthase inhibitors suppress triglyceride biosynthesis through the farnesol pathway in rat hepatocytes. J Lipid Res. 2003;44:128-35.
35. Guan G, Dai PH, Osborne TF, Kim JB, Shechter I. Multiple sequence elements are involved in the transcriptional regulation of the human squalene synthase gene. J Biol Chem. 1997;272:10295-302.